These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 11252027

  • 1. Member of the Ampakine class of memory enhancers prolongs the single channel open time of reconstituted AMPA receptors.
    Suppiramaniam V, Bahr BA, Sinnarajah S, Owens K, Rogers G, Yilma S, Vodyanoy V.
    Synapse; 2001 May; 40(2):154-8. PubMed ID: 11252027
    [Abstract] [Full Text] [Related]

  • 2. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
    Baumbarger PJ, Muhlhauser M, Zhai J, Yang CR, Nisenbaum ES.
    J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
    [Abstract] [Full Text] [Related]

  • 3. Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus.
    Arai A, Kessler M, Rogers G, Lynch G.
    J Pharmacol Exp Ther; 1996 Aug; 278(2):627-38. PubMed ID: 8768713
    [Abstract] [Full Text] [Related]

  • 4. Ampakine CX546 bolsters energetic response of astrocytes: a novel target for cognitive-enhancing drugs acting as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulators.
    Pellerin L, Magistretti PJ.
    J Neurochem; 2005 Feb; 92(3):668-77. PubMed ID: 15659236
    [Abstract] [Full Text] [Related]

  • 5. Modulatory effects of dextran sulfate and fucoidan on binding and channel properties of AMPA receptors isolated from rat brain.
    Suppiramaniam V, Vaithianathan T, Manivannan K, Dhanasekaran M, Parameshwaran K, Bahr BA.
    Synapse; 2006 Nov; 60(6):456-64. PubMed ID: 16897725
    [Abstract] [Full Text] [Related]

  • 6. Memory and the brain: unexpected chemistries and a new pharmacology.
    Lynch G.
    Neurobiol Learn Mem; 1998 Nov; 70(1-2):82-100. PubMed ID: 9753589
    [Abstract] [Full Text] [Related]

  • 7. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.
    Murray TK, Whalley K, Robinson CS, Ward MA, Hicks CA, Lodge D, Vandergriff JL, Baumbarger P, Siuda E, Gates M, Ogden AM, Skolnick P, Zimmerman DM, Nisenbaum ES, Bleakman D, O'Neill MJ.
    J Pharmacol Exp Ther; 2003 Aug; 306(2):752-62. PubMed ID: 12730350
    [Abstract] [Full Text] [Related]

  • 8. Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action.
    Arai AC, Xia YF, Rogers G, Lynch G, Kessler M.
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1075-85. PubMed ID: 12438530
    [Abstract] [Full Text] [Related]

  • 9. Ampakine CX516 ameliorates functional deficits in AMPA receptors in a hippocampal slice model of protein accumulation.
    Kanju PM, Parameshwaran K, Sims C, Bahr BA, Shonesy BC, Suppiramaniam V.
    Exp Neurol; 2008 Nov; 214(1):55-61. PubMed ID: 18687330
    [Abstract] [Full Text] [Related]

  • 10. The mechanism of action of aniracetam at synaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors: indirect and direct effects on desensitization.
    Lawrence JJ, Brenowitz S, Trussell LO.
    Mol Pharmacol; 2003 Aug; 64(2):269-78. PubMed ID: 12869631
    [Abstract] [Full Text] [Related]

  • 11. Single channel recordings from synaptosomal AMPA receptors.
    Vaithianathan T, Manivannan K, Kleene R, Bahr BA, Dey MP, Dityatev A, Suppiramaniam V.
    Cell Biochem Biophys; 2005 Aug; 42(1):75-85. PubMed ID: 15673930
    [Abstract] [Full Text] [Related]

  • 12. Positive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulators have different impact on synaptic transmission in the thalamus and hippocampus.
    Xia YF, Kessler M, Arai AC.
    J Pharmacol Exp Ther; 2005 Apr; 313(1):277-85. PubMed ID: 15626725
    [Abstract] [Full Text] [Related]

  • 13. Excitatory amino acids and neuronal plasticity: modulation of AMPA receptors as a novel substrate for the action of nootropic drugs.
    Nicoletti F, Casabona G, Genazzani AA, Copani A, Aleppo G, Canonico PL, Scapagnini U.
    Funct Neurol; 1992 Apr; 7(5):413-22. PubMed ID: 1338053
    [Abstract] [Full Text] [Related]

  • 14. Synergistic interactions between ampakines and antipsychotic drugs.
    Johnson SA, Luu NT, Herbst TA, Knapp R, Lutz D, Arai A, Rogers GA, Lynch G.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):392-7. PubMed ID: 10087029
    [Abstract] [Full Text] [Related]

  • 15. Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function.
    Parameshwaran K, Sims C, Kanju P, Vaithianathan T, Shonesy BC, Dhanasekaran M, Bahr BA, Suppiramaniam V.
    Synapse; 2007 Jun; 61(6):367-74. PubMed ID: 17372971
    [Abstract] [Full Text] [Related]

  • 16. Expression of functional kainate and AMPA receptors in developing lateral superior olive neurons of the rat.
    Vitten H, Reusch M, Friauf E, Löhrke S.
    J Neurobiol; 2004 Jun; 59(3):272-88. PubMed ID: 15146545
    [Abstract] [Full Text] [Related]

  • 17. Glutamate-based therapeutic approaches: ampakines.
    Lynch G.
    Curr Opin Pharmacol; 2006 Feb; 6(1):82-8. PubMed ID: 16361116
    [Abstract] [Full Text] [Related]

  • 18. Modulation of agonist binding to AMPA receptors by 1-(1,4-benzodioxan-6-ylcarbonyl)piperidine (CX546): differential effects across brain regions and GluA1-4/transmembrane AMPA receptor regulatory protein combinations.
    Montgomery KE, Kessler M, Arai AC.
    J Pharmacol Exp Ther; 2009 Dec; 331(3):965-74. PubMed ID: 19717789
    [Abstract] [Full Text] [Related]

  • 19. Activation of dopamine D4 receptors induces synaptic translocation of Ca2+/calmodulin-dependent protein kinase II in cultured prefrontal cortical neurons.
    Gu Z, Jiang Q, Yuen EY, Yan Z.
    Mol Pharmacol; 2006 Mar; 69(3):813-22. PubMed ID: 16365279
    [Abstract] [Full Text] [Related]

  • 20. Modulation of AMPA currents by D2 dopamine receptors in striatal medium-sized spiny neurons: are dendrites necessary?
    Hernández-Echeagaray E, Starling AJ, Cepeda C, Levine MS.
    Eur J Neurosci; 2004 May; 19(9):2455-63. PubMed ID: 15128399
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.